Sep 08, 2026 Presentations & Publications GB-0895 SOLAIRIA-1 & SOLAIRIA-2 ERS Barcelona 2026 Final Read More
Sep 08, 2026 Presentations & Publications GB-0895 COPD Phase 1 study ERS Barcelona 2026 Final Read More
Sep 06, 2026 Presentations & Publications GB-0895 Asthma Phase 1 study ERS Barcelona 2026 Final Read More
Jul 14, 2026 Presentations & Publications Randomized, Double-Blind, Placebo-Controlled First-in-Human Trial of a First-in-Class AI-Designed Monoclonal Antibody (GB-0669) Against the Conserved SARS-CoV‑2 Spike S2 Stem Helix Read More
Oct 09, 2025 Presentations & Publications First-in-Human Study of a First-in-Class AI-Designed Monoclonal Antibody (GB-0669) Against the Conserved SARS-CoV-2 Spike S2 Stem Helix View on: medRxiv
Sep 28, 2025 Presentations & Publications ERS 2025: GB-0895, a high-affinity anti-TSLP mAb, demonstrates prolonged half-life and sustained pharmacological activity supporting every 6-month dosing in asthma Read More
Apr 01, 2025 Presentations & Publications Functional and structural characterization of a combination of pan-sarbecovirus antibodies with potent antiviral activity View on: bioRxiv
Oct 15, 2024 Presentations & Publications IDWeek 2024: Machine learning-guided generation of a potent combination of broadly neutralizing sarbecovirus antibodies with a high barrier to resistance Read More
